Back to search
FDAFDA · Food and drugs·Recall number D-0891-2022

Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.

Published June 1, 2022 · Recall initiated: May 3, 2022

Summary

FDA records drug Class II recall D-0891-2022, published June 1, 2022 and initiated May 3, 2022. Recalling firm: Preferred Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 31 bottles of 90 tables (Lot: K1721D); 5 bottles of 90 tablets (K1021E).; Lot: Lot: K1721D, EXP: 4/30/2023, NDC: 68788-7758-09; Lot: K1021E, EXP: 7/31/2023, NDC: 68788-7758-09. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Preferred Pharmaceuticals, Inc.
Distributor
Within the U.S in FL and CA.
Lot
Lot: K1721D, EXP: 4/30/2023, NDC: 68788-7758-09; Lot: K1021E, EXP: 7/31/2023, NDC: 68788-7758-09.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09. recalled?

Yes. FDA published recall D-0891-2022 on June 1, 2022. Reported hazard: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit